From the Interim Director

Bruce G. Haffty, MDWelcome to Rutgers Cancer Institute of New Jersey. As the state’s only National Cancer Institute-designated Comprehensive Cancer Center, patients can be confident that they are receiving the most advanced cancer care delivered by a compassionate team of internationally recognized experts. As an NCI-designated Cancer Center, Rutgers Cancer Institute provides its patients with access to the latest medicines and technology, as well as the most advanced clinical trials including novel personalized targeted therapies available in our Precision Medicine Program. 

Our physicians and scientists are leaders in their field and are working diligently to develop new approaches to the detection, treatment and prevention of cancer through cutting-edge clinical, basic, population, and translational research all with one goal in mind - winning is everything!

As the cancer research hub for New Jersey, Rutgers Cancer Institute fosters collaborations with the State’s universities, pharmaceutical and biotechnology companies bringing breakthrough discoveries to patients at a more rapid pace. Rutgers Cancer Institute also serves as a valuable resource for New Jersey's pharmaceutical and biotechnology industries for the development of new cancer treatments.

I welcome you to explore our website and learn more about the incredible work being done at the Rutgers Cancer Institute and how we are outsmarting cancer with science.


Bruce G. Haffty, MD
Interim Director, Rutgers Cancer Institute of New Jersey
Interim Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences

precision medicine at Rutgers Cancer Institute


Donate Now



Proud member of
Big Ten Cancer Research Consortium



Rutgers Health